Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
Phase 4
Completed
- Conditions
- SurgeryNeuromuscular BlockadePneumoperitoneum
- Interventions
- Procedure: Low pressure pneumoperitoneum
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 178
- Registration Number
- NCT03608436
- Locations
- 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
🇳🇱Martini general hospital, Groningen, Netherlands
🇳🇱Maxima Medisch Centrum, Veldhoven, Netherlands
Dutch Intracerebral Hemorrhage Surgery Trial Pilot Study
Not Applicable
Completed
- Conditions
- Surgical Procedures, Minimally InvasiveIntracerebral Hemorrhage
- Interventions
- Device: Minimally-invasive endoscopy-guided surgery
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 169
- Registration Number
- NCT03608423
- Locations
- 🇳🇱
Haaglanden Medical Center, Den Haag, Netherlands
🇳🇱Academic Medical Center, Amsterdam, Netherlands
🇳🇱Maastricht University Medical Center, Maastricht, Netherlands
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
Phase 4
Completed
- Conditions
- PneumoperitoneumSurgeryImmune SuppressionNeuromuscular Blockade
- Interventions
- Procedure: Low pressure pneumoperitoneum
- First Posted Date
- 2018-06-28
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03572413
- Locations
- 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE
Phase 1
Completed
- Conditions
- Clear Cell Renal Carcinoma
- Interventions
- Diagnostic Test: 89Zr-Girentuximab
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03556046
- Locations
- 🇳🇱
Radboud University, Nijmegen, Netherlands
Effect of Dapagliflozin on IAH in T1DM
Phase 2
Completed
- Conditions
- HypoglycemiaDiabetes Mellitus, Type 1Hypoglycemia Unawareness
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT03556033
- Locations
- 🇳🇱
Radboud university medical center, Nijmegen, Netherlands
Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)
Phase 4
Completed
- Conditions
- Depressive Disorder, Major
- Interventions
- Drug: TCA treatment
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 125
- Registration Number
- NCT03548675
- Locations
- 🇳🇱
Radboudumc Dept of Psychiatry, Nijmegen, Netherlands
Dutch National Prospective EMR Cohort
Recruiting
- Conditions
- Large Bowel Polyp
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT03545061
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients
Phase 1
Completed
- Conditions
- Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
- Interventions
- Biological: UCB-NK cellsDrug: Chemotherapy
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT03539406
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE)
Phase 1
Completed
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Diagnostic Test: 89Zr-avelumab PET
- First Posted Date
- 2018-05-02
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT03514719
- Locations
- 🇳🇱
Radboud University, Nijmegen, Netherlands
Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT03513393
- Locations
- 🇳🇱
Radboud university medical Center, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath